Hypofractionated radiosurgery for intact or resected brain metastases: Defining the optimal dose and fractionation

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Eaton, Bree R ^a   Gebhardt, Brian ^a,b   Prabhu, Roshan ^a   Shu, Hui Kuo ^a   Curran, Walter J ^a   Crocker, Ian ^a  

^a EMORY UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Brain; Hypofractionated; Metastases; Radiosurgery

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN METASTASIS; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OVERALL SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RADIOSURGERY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878649850     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-135     Document Type: Article

References (23)

1. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-72. 10.1016/S0140-6736(04)16250-8, 15158627.
2. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-34.
3. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46. 10.1016/j.ijrobp.2005.05.023, 16111570.
4. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:45-68. 10.1007/s11060-009-0073-4, 2808519, 19960227.
5. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-44. 10.1016/S1470-2045(09)70263-3, 19801201.
6. Adler JR, Cox RS, Kaplan I, Martin DP. Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 1992, 76:444-9. 10.3171/jns.1992.76.3.0444, 1738025.
7. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995, 87:34-40. 10.1093/jnci/87.1.34, 7666461.
8. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291-8. 10.1016/S0360-3016(99)00507-6, 10802351.
9. Aoki M, Abe Y, Hatayama Y, Kondo H, Basaki K. Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys 2006, 64:414-8. 10.1016/j.ijrobp.2005.03.017, 16271441.
10. Aoyama H, Shirato H, Onimaru R, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 2003, 56:793-800. 10.1016/S0360-3016(03)00014-2, 12788187.
11. De Potter B, De Meerleer G, De Neve W, Boterberg T, Speleers B, Ost P. Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases. Neurol Sci 2013, 34(5):647-653. Official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 10.1007/s10072-012-1091-0, 22526765.
12. Giubilei C, Ingrosso G, D'Andrea M, Benassi M, Santoni R. Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases. J Neurooncol 2009, 91:207-12. 10.1007/s11060-008-9700-8, 18807149.
13. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 2009, 115:890-8. 10.1002/cncr.24082, 19132728.
14. Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 2005, 61:1460-6. 10.1016/j.ijrobp.2004.08.027, 15817351.
15. Narayana A, Chang J, Yenice K, et al. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 2007, 85:82-7. 10.1159/000097923, 17167236.
16. Ogura K, Mizowaki T, Ogura M, et al. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors. J Neurooncol 2012, 109(2):425-432.
17. Wang CC, Floyd SR, Chang CH, et al. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy x 3 daily fractions regimen. J Neurooncol 2012, 106:601-10. 10.1007/s11060-011-0697-z, 21879395.
18. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiotherapy and oncology. J Eu Soc Therap Radio Oncol 2006, 81:18-24.
19. Fahrig A, Ganslandt O, Lambrecht U, et al. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft 2007, 183:625-630.
20. Eric J, Hall AJG. Radiobiology for the radiologist 2006, Philadelphia, PA: Lippincott Williams and Wilkins, 6.
21. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:847-52. 10.1016/j.ijrobp.2007.10.059, 18262098.
22. Dhabaan A, Schreibmann E, Siddiqi A, et al. Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgery. J app clin med phy/Am College Med Phy 2012, 13:3916.
23. Prabhu RS, Dhabaan A, Hall WA, et al. Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. J Neurooncol 2013, 113(1):93-99. 10.1007/s11060-013-1093-7, 23440526.